Papers
6
Total Citations
97
H-Index
4
About
Zheng Zhang is a urological surgeon and clinical researcher whose work sits at the intersection of robotic surgery innovation and minimally invasive urology. His most significant contributions center on the clinical validation of the KangDuo Surgical Robot (KD-SR), a domestically developed Chinese robotic platform designed as an alternative to the globally dominant da Vinci system. Through rigorous prospective, randomized controlled trials — a methodological gold standard — Zhang has demonstrated the KD-SR's noninferiority to established systems for both robot-assisted partial nephrectomy and radical prostatectomy, work that has collectively garnered over 80 citations and carries meaningful implications for expanding affordable robotic surgical access globally. His 2022 noninferiority trial comparing KD-SR to the da Vinci Si for partial nephrectomy (54 citations) stands as his most impactful contribution to date. Beyond surgical robotics, Zhang has contributed to renal tumor classification through the development of the ADDD nephrometry scoring system, offering a refined anatomical framework for surgical planning. His earlier materials science work on elastomer surface modification further reflects a versatile research background. Zhang's portfolio positions him as a key figure in China's growing robotic surgery landscape.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6